Intraperitoneal Administration of Fosfomycin, Metronidazole and Molgramostim Versus Intravenous Antibiotics for Perforated Appendicitis

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

February 14, 2018

Primary Completion Date

July 17, 2018

Study Completion Date

July 17, 2018

Conditions
Appendicitis Perforated
Interventions
DRUG

Combination of fosfomycin, metronidazole and rhGM-CSF (administered together intraperitoneally) and three days of antibiotics p.o.

All drugs will be administered together intraperitoneally at the end of the surgery after the appendix has been removed. Hereafter, the intervention group will receive three days of orally administered antibiotics: 500 mg amoxicillin combined with 125 mg clavulanic acid and 500 mg metronidazole. These doses will be administered three times daily.

DRUG

Standard antibiotics intravenously

4 g piperacillin/500 mg tazobactam and 1 g metronidazole administered intravenously during surgery followed by 4 g piperacillin/500 mg tazobactam and 500 mg metronidazole administered intravenously three times daily for three days.

Trial Locations (2)

2400

Department of Surgery, Bispebjerg Hospital, Copenhagen

2730

Department of Surgery, Herlev Hospital, Herlev

All Listed Sponsors
collaborator

Bispebjerg Hospital

OTHER

lead

Herlev Hospital

OTHER

NCT03435900 - Intraperitoneal Administration of Fosfomycin, Metronidazole and Molgramostim Versus Intravenous Antibiotics for Perforated Appendicitis | Biotech Hunter | Biotech Hunter